S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
S&P 500   3,353.77 (-0.96%)
DOW   29,055.91 (-1.00%)
QQQ   233.24 (-1.58%)
AAPL   319.41 (-1.30%)
FB   214.21 (-1.51%)
MSFT   182.99 (-2.29%)
GOOGL   1,511.67 (-0.87%)
AMZN   2,140.30 (-1.38%)
CGC   22.36 (+2.71%)
NVDA   303.91 (-3.43%)
BABA   216.00 (-2.76%)
MU   58.48 (-2.52%)
GE   12.50 (-0.87%)
AMD   56.99 (-3.24%)
T   38.42 (-0.05%)
ACB   1.69 (-1.17%)
F   8.01 (+0.13%)
BAC   34.69 (-0.09%)
DIS   139.42 (-1.33%)
GILD   66.41 (-1.40%)
Log in

NASDAQ:UBIO - ProShares UltraPro NASDAQ Biotechnology Stock Price, Forecast & News

$33.00
-1.56 (-4.51 %)
(As of 02/20/2020 12:09 PM ET)
Add
Today's Range
$33.00
Now: $33.00
$34.47
50-Day Range
$27.26
MA: $31.83
$33.98
52-Week Range
$17.05
Now: $33.00
$35.36
Volume25,904 shs
Average Volume34,967 shs
Market Capitalization$24.75 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Basic Details

Issuer ProShares
Fund NameProShares UltraPro NASDAQ Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:UBIO
Inception Date6/22/2015
Fund ManagerMichael Neches, Tarak Dave
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ Biotechnology Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$27.06 million
Average Daily Volume$58,712.30
Discount/Premium-0.04%

ETF Expenses

Management Fee0.75%
Other Expenses0.57%
Total Expenses1.32%
Fee Waiver-0.37%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial

Receive UBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for UBIO and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO)
Currency Exposure of ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO)
Sector Exposure of ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO)
Industry Exposure of ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO)

ProShares UltraPro NASDAQ Biotechnology (NASDAQ:UBIO) Frequently Asked Questions

What is ProShares UltraPro NASDAQ Biotechnology's stock symbol?

ProShares UltraPro NASDAQ Biotechnology trades on the NASDAQ under the ticker symbol "UBIO."

Has ProShares UltraPro NASDAQ Biotechnology been receiving favorable news coverage?

Press coverage about UBIO stock has trended very negative on Thursday, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProShares UltraPro NASDAQ Biotechnology earned a news sentiment score of -3.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for ProShares UltraPro NASDAQ Biotechnology.

What other stocks do shareholders of ProShares UltraPro NASDAQ Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraPro NASDAQ Biotechnology investors own include Energous (WATT), Shopify (SHOP), Amarantus Bioscience (AMBS), NVIDIA (NVDA), Markel (MKL), Square (SQ), Adobe (ADBE), Baidu (BIDU), Booking (BKNG) and WisdomTree Japan Hedged SmallCap Equity Fund (DXJS).

Who are ProShares UltraPro NASDAQ Biotechnology's major shareholders?

ProShares UltraPro NASDAQ Biotechnology's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Jane Street Group LLC (7.53%) and Tower Research Capital LLC TRC (0.68%).

Which major investors are selling ProShares UltraPro NASDAQ Biotechnology stock?

UBIO stock was sold by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC .

Which major investors are buying ProShares UltraPro NASDAQ Biotechnology stock?

UBIO stock was bought by a variety of institutional investors in the last quarter, including Jane Street Group LLC.

How do I buy shares of ProShares UltraPro NASDAQ Biotechnology?

Shares of UBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ProShares UltraPro NASDAQ Biotechnology's stock price today?

One share of UBIO stock can currently be purchased for approximately $33.00.

How big of a company is ProShares UltraPro NASDAQ Biotechnology?

ProShares UltraPro NASDAQ Biotechnology has a market capitalization of $24.75 million. View Additional Information About ProShares UltraPro NASDAQ Biotechnology.


MarketBeat Community Rating for ProShares UltraPro NASDAQ Biotechnology (NASDAQ UBIO)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  157
MarketBeat's community ratings are surveys of what our community members think about ProShares UltraPro NASDAQ Biotechnology and other stocks. Vote "Outperform" if you believe UBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel